0.8173
Heron Therapeutics Inc (HRTX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
6.22%
40.59
|
38.21 | 37.20 | 38.90 | 40.78 |
| Cost Of Revenue |
6.67%
11.12
|
11.91 | 9.857 | 8.457 | 10.23 |
| Gross Profit |
12.05%
29.47
|
26.30 | 27.34 | 30.45 | 30.55 |
|
|
3.16%
29.43
|
30.39 | 28.98 | 27.29 | 26.38 |
| Benefits Costs and Expenses |
43.27%
43.54
|
30.39 | 28.98 | 27.29 | 26.38 |
| Costs And Expenses |
3.16%
29.43
|
30.39 | 28.98 | 27.29 | 26.38 |
| Operating Income/Loss |
100.93%
0.038
|
-4.093 | -1.637 | 3.154 | 4.173 |
| Income/Loss From Continuing Operations Before Tax |
137.77%
-2.954
|
7.821 | -2.381 | 2.635 | 14.40 |
| Income/Loss From Continuing Operations After Tax |
83.12%
-2.954
|
-17.50 | -2.381 | 2.635 | 3.663 |
|
|
83.12%
-2.954
|
-17.50 | -2.381 | 2.635 | 3.663 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
95.78%
7.183
|
170.35 | 154.02 | 153.49 | 0.236 |
| Diluted Average Shares |
95.78%
7.183
|
170.35 | 154.02 | 196.92 | 0.236 |
| Basic Earnings Per Share |
90.00%
-0.010
|
-0.10 | -0.02 | 0.02 | 0.02 |
| Diluted Earnings Per Share |
90.00%
-0.010
|
-0.10 | -0.02 | 0.01 | 0.02 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):